A research team has developed a combination immunotherapy that uses an electrical ablation technique to enhance the efficacy of immune cell therapy against liver cancer.
Endeavor Health joins Chicago Breast Cancer Research Consortium Evanston RoundTable
47 Physicians Collaborate to Expand Access to Daraxonrasib for Patients With Pancreatic Cancer - Clinical Trials Program Oncodaily
A new study in the Journal of the American College of Radiology has found that automated breast ultrasound (ABUS) and handheld ultrasound (HHUS) had similar cancer detection rates in women with dense breasts, while ABUS had a lower false-positive rate. The study demonstrates that ABUS is a viable alternative to HHUS…
“The World Needs Leaders Who Turn Vision Into Change” - Ivane Kiladze, Head of the Oncology Department at Caucasus Medical Center, on Dr. Gevorg Tamamyan’s Candidacy for WHO Director-General Oncodaily
Age-Based Genetic Testing Criteria May Overlook Inherited Cancer Risk Targeted Oncology
5 Years of Liver Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients Cure Today
EORTC Summit on Clinical Cancer Research Oncodaily
Our bodies contain immune cells called macrophages. Normally, these cells attack and suppress bacteria and cancer cells. However, when macrophages infiltrate tumors, they can become tumor-associated macrophages (TAMs) and can switch to an immunosuppressive, anti-inflammatory state.
WMA GmbH – 13th Immunotherapy of Cancer Conference (ITOC13) Oncodaily
Scientists at The Wistar Institute have identified a combination treatment that overcomes two of the biggest barriers to immunotherapy in glioblastoma. In a study published in Neuro-Oncology, the researchers show that reprogramming myeloid cells, a type of immune cell that glioblastoma tumors co-opt to protect…
CPRIT honors UTSW’s Argenbright with Texans Conquer Cancer Award: Newsroom UT Southwestern
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer Oncology Nursing News